Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

Enrolling by invitation

Conditions studied: Interstitial Lung Disease, COPD, Cystic Fibrosis, Pulmonary Fibrosis, Pulmonary Arterial Hypertension, Emphysema

In brief

The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved and transported within the LUNGguard system, as well as retrospective standard of care patients

Key facts

Study ID
NCT04930289
Run by
Paragonix Technologies
People needed
2000
Starts
2021-10-15
Expected to finish
2029-12-30
Last updated by the study team
2025-05-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.